Thanks for subscribing!
Ymmunobio to Present at the Annual Meeting of the Association for Cancer Immunotherapy (CIMT)
Ymmunobio Appoints New Chief Operating Officer
Ymmunobio Accepted into Innosuisse Core Coaching
Dr. Katrin Rupalla Interviewed by Global Business Reports
Drug Discovery & Development
Fierce Biotech: Appointment of Michel Janicot
Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy ...